Latest Insider Transactions at Phathom Pharmaceuticals, Inc. (PHAT)
This section provides a real-time view of insider transactions for Phathom Pharmaceuticals, Inc. (PHAT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phathom Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phathom Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
117,600
+2.98%
|
$2,822,400
$24.86 P/Share
|
|
Mar 31
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,600
+0.82%
|
$734,400
$24.55 P/Share
|
|
Mar 27
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.81%
|
$720,000
$24.6 P/Share
|
|
Jan 05
2020
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
1,854
-0.22%
|
$61,182
$33.77 P/Share
|
|
Jan 04
2020
|
Azmi Nabulsi Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
12,646
-0.5%
|
$417,318
$33.84 P/Share
|
|
Oct 29
2019
|
Michael F Cola |
BUY
Open market or private purchase
|
Direct |
9,798
+50.0%
|
$186,162
$19.0 P/Share
|